Form 4 for URGN UroGen Pharma Ltd.
Accepted 2022-09-16 00:00:00 ET · period of report 2022-09-14 · accession 0001437749-22-022616 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-09-16 | 2022-09-14 | URGN | Belldegrun Arie | Dir | M - OptEx | $5.00 | +160.0K | 408.7K | +64% | +$800.0K |
| D | 2022-09-16 | 2022-09-14 | URGN | Belldegrun Arie | Dir | M - OptEx | $0.00 | -160.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-09-14 | M | A | 160,000 | $5.00 | 408,693 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2022-09-14 | M | D | 160,000 | $0.00 | 0 | D | $5.00 · 2019-10-07 to 2022-10-07 | 160,000 Ordinary Shares |